Pharmaceutical Preparations · DE · CIK 1855175
Contineum Therapeutics pioneers differentiated small molecule therapies for neurological and inflammatory indications with unmet needs
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 3 sold $627K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 4,170 | $15.01 | $63K |
| Mar 2, 2026 | Watkins TimCMO & Head of Development | Sell | 3,611 | $15.02 | $54K |
| Feb 25, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 3,824 | $16.01 | $61K |
| Feb 25, 2026 | Stengone Carmine N.CEO and President | Sell | 2,700 | $16.02 | $43K |
| Feb 24, 2026 | Stengone Carmine N.CEO and President | Sell | 4,400 | $16.02 | $70K |
| Feb 24, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 4,300 | $16.03 | $69K |
| Feb 19, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 100 | $16.00 | $2K |
| Feb 11, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 400 | $16.00 | $6K |
| Feb 11, 2026 | Stengone Carmine N.CEO and President | Sell | 400 | $16.00 | $6K |
| Feb 3, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 3,000 | $14.82 | $44K |
| Feb 3, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 1,170 | $15.25 | $18K |
| Jan 28, 2026 | Watkins TimCMO & Head of Development | Sell | 2,800 | $14.09 | $39K |
| Jan 28, 2026 | Watkins TimCMO & Head of Development | Sell | 811 | $14.48 | $12K |
| Jan 5, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 3,670 | $10.35 | $38K |
| Jan 5, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sell | 500 | $11.13 | $6K |
| Dec 29, 2025 | Watkins TimCMO & Head of Development | Sell | 3,611 | $12.06 | $44K |
| Dec 23, 2025 | Lorrain Daniel S.Chief Scientific Officer | Sell | 4,170 | $12.23 | $51K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.